Improving the quality of surveillance colonoscopy in inflammatory bowel disease.

Marietta Iacucci, Rosanna Cannatelli, Gian Eugenio Tontini, Remo Panaccione, Silvio Danese, Gionata Fiorino, Takayuki Matsumoto, Gursimran S Kochhar, Bo Shen, Ralf Kiesslich, Subrata Ghosh

Journal: The lancet. Gastroenterology & hepatology 2020;4(12):971-983

PMID: 31696831

Full Text on Elsevier Science View on PubMed

Abstract

Several recommendations have addressed the topic of improving the quality of surveillance colonoscopy in inflammatory bowel disease. However, there is variation between these recommendations, in part due to the absence of well-defined quality indicators, suggesting that these quality indicators should be studied and developed. We did a systematic review of evidence related to surveillance colonoscopy in inflammatory bowel disease to look at the different variables in this practice and offer a critique of the quality control measures before, during, and after the procedure. We identified several key quality measures that could be adopted in clinical practice, including control of inflammation, optimal bowel preparation, ideal time allocation, training, sedation, detection and characterisation of lesions, therapeutic management of the lesions, and colonoscopic reports. However, further primary research and consensus reports are needed to continue developing roadmaps at a global level.

Address: Institute of Translational of Medicine, NIHR Biomedical Research Centre, University of Birmingham and University Hospitals, Birmingham NHS Foundation Trust, Birmingham, UK; Institute of Immunology and Immunotherapy, NIHR Biomedical Research Centre, University of Birmingham and University Hospitals, Birmingham NHS Foundation Trust, Birmingham, UK. Electronic address: [email protected].; Institute of Translational of Medicine, NIHR Biomedical Research Centre, University of Birmingham and University Hospitals, Birmingham NHS Foundation Trust, Birmingham, UK; Institute of Immunology and Immunotherapy, NIHR Biomedical Research Centre, University of Birmingham and University Hospitals, Birmingham NHS Foundation Trust, Birmingham, UK; Department of Gastroenterology, Spedali Civili di Brescia, University of Milan, Milan, Italy.; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy; Gastroenterology and Endoscopy Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Department of Gastroenterology and Hepatology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.; Inflammatory Bowel Diseases Center, Department of Gastroenterology, Humanitas Research Hospital, Rozzano, Milan, Italy.; Inflammatory Bowel Diseases Center, Department of Gastroenterology, Humanitas Research Hospital, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.; Department of Gastroenterology, Iwate Medical University, Morioka, Japan.; Department of Gastroenterology, Allegheny General Hospital, Pittsburgh, PA, USA.; Department of Gastroenterology, Hepatology & Nutrition, Cleveland Clinic, Cleveland, OH, USA.; Department of Medicine, Helios HSK Wiesbaden, Wiesbaden, Germany.; Institute of Translational of Medicine, NIHR Biomedical Research Centre, University of Birmingham and University Hospitals, Birmingham NHS Foundation Trust, Birmingham, UK; Institute of Immunology and Immunotherapy, NIHR Biomedical Research Centre, University of Birmingham and University Hospitals, Birmingham NHS Foundation Trust, Birmingham, UK.

DOI: 10.1016/S2468-1253(19)30194-3

Link outs

Free resources

Medical:

https://medlineplus.gov/colorectalcancer.html

Subscription / membership required

Full Text Sources:

https://linkinghub.elsevier.com/retrieve/pii/S2468...

MeSH Terms: Colonoscopy, Colorectal Neoplasms, Humans, Inflammatory Bowel Diseases, Population Surveillance, Quality Improvement